The IRMA Community
Newsletters
Research IRM
Click a keyword to search titles using our InfoSci-OnDemand powered search:
|
Enzyme-Assisted Wastewater Treatment in the Pharmaceutical Industry
|
|
Author(s): Nisha Gaur (Department of Biotechnology, Gautam Buddha University, Greater Noida, India), Mohit Yadav (O.P. Jindal Global University, Sonipat, India), Rashika Singh (Department of Biotechnology, Gautam Buddha University, Greater Noida, India), Ayan Sheikh (Department of Biotechnology, Gautam Buddha University, Greater Noida, India), Vaishnavi Shrivastava (Department of Biotechnology, Gautam Buddha University, Greater Noida, India)and Xuan-Hoa Nghiem (Vietnam National University, Hanoi, Vietnam)
Copyright: 2025
Pages: 26
Source title:
Biotechnology Approaches to Industrial and Pharmaceutical Wastewater Treatment
Source Author(s)/Editor(s): Ajmer Singh Grewal (Guru Gobind Singh College of Pharmacy, Yamuna Nagar, India), Geeta Deswal (Guru Gobind Singh College of Pharmacy, Yamuna Nagar, India)and Arun Lal Srivastav (Chitkara University, India)
DOI: 10.4018/979-8-3693-8487-9.ch013
Purchase
|
Abstract
The pharmaceutical industry is a significant source of environmental pollution; the main environmental concern being the presence of residues from pharmaceutical products within water bodies. Methods used to treat wastewater traditionally involve physical and chemical processes, which lack desirable characteristics since they result in high costs, consume large amounts of energy, and produce toxic byproducts. The use of enzymes in wastewater treatment appears as an effective and sustainable alternative. For instance, oxidoreductases, lipases, and proteases catalyze at mild conditions and could split pharmaceutical complex pollutants into less harmful forms. Enzymatic processes are friendly to the environment and may minimize the creation of toxic byproducts. An illustration is cases that have indicated successful pharmaceuticals, such as diclofenac and triclosan, could be degraded using laccase. Some technical difficulties in the process need to be overcome: complex techniques of enzyme immobilization, for instance, and high setup costs.
Related Content
|
Ashutosh Shukla, Anupamaa Shukla, Parjanya Kumar Shukla.
© 2025.
32 pages.
|
|
Vaishali Varshney, Neelanchal Trivedi, Bhuvnesh Kumar Singh, Ashok Kumar Rajpoot, Vikas Kumar Singh.
© 2025.
48 pages.
|
|
Anjali Sharma, Vishnu Mittal, Devkant Sharma.
© 2025.
28 pages.
|
|
Prakash Baburao Rathod, Mahendra P. Singh, Uddhav S. Markad.
© 2025.
32 pages.
|
|
Richa Gupta, Anuradha Anuradha, Abhilekha Sharma, Dipti Bharti, Vaishnavi Srivastava.
© 2025.
34 pages.
|
|
Tarun Kumar Patel.
© 2025.
34 pages.
|
|
Ravi Berwal, Himanshi Tanwar.
© 2025.
34 pages.
|
|
|